Focus

Life Science Investors: Angels and VC Firms

The RaiseHunt database lists 3,754 Life Science investors: 172 angel investors and 3,582 people at 737 firms. Most list Seed and Series A among their stages; the largest hubs are New York, San Francisco and Boston.

Strongest in New York, San Francisco and Boston

Common stages: Seed and Series A

3,754
Life Science investors
172
Angel investors
3,582
People at VC/PE firms
737
Firms tagged

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

3,754 Life Science investors

Showing 1-20

Filters
Milwaukee, United States
AngelOperator angel
ConsumerHardware
View profile
Emre Acikel
Emre Acikel

General Partner

Geneva, Switzerland
Angel
CommerceConsumer
View profile
London, United Kingdom
AngelOperator angel
AIHealthcare
View profile
Santa Monica, United States
Angel
ClimateEnergy
View profile
Amit Sangani
Amit Sangani

Limited Partner & Investor

Los Altos, United States
Angel
AIConsumer
View profile
New York, United States
AngelSyndicate / Angel group
ConsumerHealthcare
View profile
Sunil Kumar Reddy S
Sunil Kumar Reddy S

angel investor

Hyderabad, India
Angel
FinTechFood
View profile
Steve Hissong
Steve Hissong

angel investor and operator angel

Seattle, United States
AngelOperator angel
FinTechHealthcare
View profile
Peter Gassner
Peter Gassner

angel investor and operator angel

Pleasanton, United States
AngelOperator angel
AIHealthcare
View profile
Frank Hensel
Frank Hensel

angel investor

Angel
Healthcare
View profile
Richard Graves
Richard Graves

angel investor and operator angel

Washington, United States
AngelOperator angel
AIHealthcare
View profile
Ryan Shelswell
Ryan Shelswell

angel investor and operator angel

Sydney, Australia
AngelOperator angel
FinTechHealthcare
View profile
Rajeev Ram
Rajeev Ram

angel investor and operator angel

United States
AngelOperator angel
AIEducation
View profile
Fred Khosravi
Fred Khosravi

angel investor and operator angel

Campbell, United States
AngelOperator angel
AIHealthcare
View profile
Lars Hedbys
Lars Hedbys

angel investor

Lund, Sweden
Angel
Healthcare
View profile
James B Gambrell
James B Gambrell

angel investor and operator angel

Monaco
AngelOperator angel
HardwareHealthcare
View profile
David Allison
David Allison

angel investor and operator angel

Malibu, United States
AngelOperator angel
Healthcare
View profile
R.J. Lewis
R.J. Lewis

angel investor and operator angel

Trenton, United States
AngelOperator angel
HealthcareSaaS
View profile
Alon Lazarus
Alon Lazarus

angel investor

Israel
Angel
Healthcare
View profile
Paris, France
Angel
ConsumerFinTech
View profile

900 of 3,754 Life Science investors, A to Z

Grouped by first letter. Name and profile link only, the detailed rows are in the table above.
Show

A84

B31

C62

D58

E30

F14

G28

H22

I9

J129

K43

L32

M90

N25

O5

P40

Q2

R51

S66

T43

U1

V14

W5

Y9

Z7

Frequently asked questions

How many Life Science investors are on RaiseHunt?

RaiseHunt currently lists 3,754 Life Science investors.

Are Life Science investors angels or funds?

Both. 172 are angel investors putting in their own money, and 3,582 are people making investment decisions at 737 firms.

Where are most Life Science investors based?

The largest concentrations are in New York, San Francisco and Boston.

What stage do Life Science investors invest at?

Most list Seed and Series A among the rounds they take part in.

How do I contact Life Science investors?

Every profile shows whether an email address is on file. The addresses themselves, along with AI matching and outreach, are in the RaiseHunt app.

Is the list of Life Science investors free to browse?

Yes. The directory and every profile page are free to read. Matching your own startup against them requires an account.

Do Life Science investors only back Life Science companies?

No. A focus area is a signal of interest, not a restriction. Investors usually list several, and the useful question is whether their existing portfolio looks like the kind of company you are building.

What if no Life Science investor replies?

Usually the list was too short or too loosely matched, not that the company is unfundable. Widen it, tighten who you are writing to, and rewrite the first two lines of the message. Those lines decide whether anything below them gets read.

What is the difference between an angel investor and a VC fund?

An angel invests their own money and can decide alone, which usually makes the process shorter. A fund invests money it raised from other people, so it answers to those backers and normally runs a longer diligence process before it commits. Founders often raise from angels first and bring in a fund once there is more to show.

How many Life Science investors should I contact?

Far more than feels comfortable. Response rates on cold outreach are low even when the fit is good, so a list of a handful of perfect names tends to stall. Build a long list, sort it by how well each one matches what you are building, and work down it in batches rather than sending everything at once.

What should I have ready before reaching out?

A short deck, a one-paragraph description of what you do and who it is for, and a clear number for how much you are raising. Investors read the first two lines before they decide whether to open the deck, so those lines matter more than the rest of the document.

Does a warm introduction still matter?

It helps, mostly because it moves your email out of a crowded inbox. It is not a requirement. A cold message that shows you understand what someone has already backed, and why your company fits that pattern, gets read more often than a vague introduction from a distant contact.

Data: RaiseHunt investor dataset · Snapshot 26 September 2026 · How this data is built · Report a correction or request removal